Setrusumab (BPS 804) is a fully human monoclonal antibody that specifically targets sclerostin, a protein involved in the negative regulation of bone formation. By inhibiting sclerostin, Setrusumab enhances bone formation and improves bone strength. This antibody is primarily utilized in research focused on Osteogenesis Imperfecta (OI) and various cancer models where bone density and strength are of interest. Setrusumab offers a valuable tool for researchers studying the pathophysiology and potential therapeutic interventions for disorders associated with compromised bone integrity.
Setrusumab (BPS 804) is a fully human monoclonal antibody that specifically targets sclerostin, a protein involved in the negative regulation of bone formation. By inhibiting sclerostin, Setrusumab enhances bone formation and improves bone strength. This antibody is primarily utilized in research focused on Osteogenesis Imperfecta (OI) and various cancer models where bone density and strength are of interest. Setrusumab offers a valuable tool for researchers studying the pathophysiology and potential therapeutic interventions for disorders associated with compromised bone integrity.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
